RE:RE:RE:RE:RE:FINANCIAL "BREAKDOWN"Not in my eyes. I just didn't feel like going in depth today! Some of what you say in that post is opinion too and those we mostly disagree. One part especially. Financials were excellent and my concern was that there might be slippage from the clinics growth but that remained steady and now 4 quarters in a row with improved sales numbers.
The losses you mention, need to be clarified as I have in the past. Not all losses are cash losses and are paper losses. Also, no one buys spec stocks for 14 cents expecting a P/E of 10. Its expected that start ups lose money and where one needs to look is more how they spent the money, not if they have losses.
Repeating again. Almost all pot stocks are posting losses but it does not stop the stock price from going up. Nor did it do that last year at this very stock who was posting losses. It went up and that is proof your opinion is faulty.
Also, no financial guy uses one metric, in big caps or small caps. I remember fighing with the GLH crowd and Chris Parry who insisted those giant $3 million US revenues showed it was worth more than Canopy. Said the same thing then to the same kind of fools. You can't understand a companies future by looking at one element. I was right then, and I am right now. Canopy has not made a dollar yet and is the number one stock in the space. At one time it sucked too.